| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 11/07/2006 | US7132408 Composition and method for inhibiting platelet aggregation |
| 11/02/2006 | US20060247261 Pyrimidine compounds |
| 10/25/2006 | EP1713541A1 Use of alkaline phosphatase for the detoxification of lps |
| 10/25/2006 | EP1713506A1 Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration |
| 10/25/2006 | EP1713480A2 The use of quaternary pyridinium salts as vasoprotective agents |
| 10/25/2006 | EP1713479A1 Nk-1 receptor antagonists anesthesia recovery |
| 10/25/2006 | CN1850108A Medical hemostasis anti-adhesive irrigation solution |
| 10/18/2006 | CN1279975C Inducer of blood vessel neogenesis |
| 10/17/2006 | US7122635 Method and composition for angiogenesis inhibition |
| 10/17/2006 | US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 10/11/2006 | CN1278718C Traditional Chinese medicine compound preparation for preventing and treating intestinal adhesion and uses |
| 10/11/2006 | CN1278693C Anti-adhesion drug composition and its preparation and application |
| 10/10/2006 | US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 10/04/2006 | CN1839875A Surgical flush fluid and its preparing process and application |
| 10/04/2006 | CN1277533C Use of emodin and extracts containing emodin in preparing medicine for treating enterogastric functions after operation and preventing intestinal adhesion |
| 10/03/2006 | CA2189221C Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 09/28/2006 | US20060217407 Compositions and Formulations of 9-Nitrocamptothecin Polymorphs and Methods of Use Therefor |
| 09/27/2006 | EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
| 09/27/2006 | EP1461062B1 Composition and method for treating chronic allograft rejection |
| 09/26/2006 | US7112607 Antihypoxic agents, antiischamic agents, antiarrhythmia agents |
| 09/21/2006 | US20060210550 Angiogenesis inducer |
| 09/20/2006 | EP1701733A1 Surface protection of exposed biological tissues |
| 09/20/2006 | EP1404815B1 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060204489 Protein C derivatives |
| 09/13/2006 | CN1831003A Polypeptide organic compounds and application in xenogeneic transplantation |
| 09/12/2006 | US7105546 Useful for treating or preventing neuronal damage associated with neurological diseases |
| 09/08/2006 | WO2006093276A1 Pluripotent stem cell derived from cardiac tissue |
| 09/08/2006 | CA2600653A1 Pluripotent stem cell derived from cardiac tissue |
| 09/07/2006 | US20060199766 Pharmaceutical composition comprising a factor VIIa and a factor XIII |
| 09/07/2006 | US20060198871 Methods for treating neovascularization and intravitreal implants |
| 09/06/2006 | EP1401441A4 Allosteric adenosine receptor modulators |
| 09/06/2006 | EP1259241B8 The use of scopolamine salts |
| 09/06/2006 | CN1827109A Lyophilized injection powder using Lanluodier and its salt as active ingredients and preparing technique therefor |
| 09/05/2006 | US7101860 Composition and method for inhibiting platelet aggregation |
| 09/05/2006 | US7101550 Agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194727 Prevention and reduction of blood loss |
| 08/30/2006 | CN1826321A Quinolone derivative or its salt |
| 08/30/2006 | CN1272345C Silensed anti-CD 28 antibodies and use thereof |
| 08/30/2006 | CN1272020C Composition of hypochlorous acid and its applications |
| 08/30/2006 | CN1272019C Medical composite chitinamine gel |
| 08/30/2006 | CN1272005C Ligustrazine microcapsule and preparation method |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7097986 For use in pharmaceutical and diagnostic formulations |
| 08/29/2006 | CA2373410C A2a receptor agonists |
| 08/17/2006 | WO2006085688A1 Psychogenic pain therapeutic agent |
| 08/16/2006 | CN1817883A New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
| 08/10/2006 | US20060177481 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 08/09/2006 | EP1453832B1 Ring fused pyrazole derivatives |
| 08/09/2006 | EP1181026B1 Improved method for treating mammals with modified mammalian blood |
| 08/09/2006 | CN1268400C Synechia inhibitory material |
| 08/02/2006 | EP1274692B1 Quinazoline compounds |
| 07/25/2006 | US7081513 Peptides having Chemotaxis Inhibitory Protein from Staphylococcus aureus (CHIPS) activity for diagnosis, prophylaxis and treatment of inflammation and HIV |
| 07/25/2006 | US7081468 Angiogenesis inhibitors; antitumor agents; skin disorders; antiarthritic agents |
| 07/19/2006 | CN1264578C Carrier with solid fibrinogen and solid thrombin |
| 07/11/2006 | US7074766 antiinflammatory agents; autoimmune diseases; thrombosis; viricides; blood disorders; antitumor agents |
| 07/11/2006 | CA2170754C Injectable compositions for soft tissue augmentation |
| 07/06/2006 | US20060148806 Quinolone derivative or salt thereof |
| 07/06/2006 | US20060148738 Preventive for adhesion following abdominal surgery |
| 07/05/2006 | EP1675459A1 Use of boranocarbonates for the therapeutic delivery of carbon monoxide |
| 07/05/2006 | EP1259241B1 The use of scopolamine salts |
| 07/05/2006 | CN1262668C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 07/04/2006 | US7071202 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 06/29/2006 | WO2006068225A1 Method of inducing differentiation of skeletal muscle cell |
| 06/29/2006 | CA2592470A1 Method for inducing differentiation to skeletal muscle cells |
| 06/22/2006 | WO2006064686A1 Drug and method for preventing or relieving delayed nerve cell death |
| 06/22/2006 | US20060135555 Ring fused pyrazole derivatives as CRF antagonists |
| 06/21/2006 | EP1450781B1 Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 06/20/2006 | US7064107 Prevention and reduction of blood loss |
| 06/14/2006 | EP1669091A2 Therapeutic inhibitor of vascular smooth muscle cells |
| 06/14/2006 | EP1667620A2 Active body cooling with vasodilation to reduce body temperature |
| 06/14/2006 | CN1259049C Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 06/08/2006 | WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 06/08/2006 | US20060122101 Drug for preventing, regulating or treating adhesion |
| 06/08/2006 | US20060121125 Formulation which can be administered gastrointestinally, containing green tea extract and an no donor |
| 06/08/2006 | CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | US7056722 Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| 06/01/2006 | WO2006057432A1 Conjunctival filtration bleb forming agent and use thereof |
| 06/01/2006 | WO2006057270A1 Nitrogeneous tricyclic compound |
| 06/01/2006 | WO2006056800A1 Use of phospholipids for wound healing |
| 06/01/2006 | US20060115542 Therapeutic delivery of carbon monoxide |
| 06/01/2006 | CA2589285A1 Use of phospholipids for wound healing |
| 05/31/2006 | EP1660098A1 Use of surfactant preparations for the treatment of surgical adhesions |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/31/2006 | CN1257752C Multifunction biological compatible aquogel and producing process thereof |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/26/2006 | WO2006054624A1 Adhesion preventive and method of preventing adhesion |
| 05/26/2006 | CA2585502A1 Adhesion preventive and method of preventing adhesion |
| 05/25/2006 | US20060111375 Compound having tgfß inhibitory activity and medicinal composition containing the same |
| 05/25/2006 | US20060111374 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 05/23/2006 | US7049322 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 05/18/2006 | US20060105991 Medical composition for protuberance of epithelium |
| 05/17/2006 | EP1543003B1 Imidazo¬1,2-a|pyridines |
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
| 05/16/2006 | US7045140 Therapeutic delivery of carbon monoxide |